| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/06/2001 | WO2001034130A9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 12/06/2001 | WO2001032146A3 Amphiphilic polymeric vesicles |
| 12/06/2001 | WO2001032031A3 Cholesterol reducing sterol compositions, preparation and method of use |
| 12/06/2001 | WO2001024788A3 Treating endometriosis or infertility, or improving fertility |
| 12/06/2001 | WO2001023362A3 Rate-controlled particles |
| 12/06/2001 | WO2001022922A3 Engineering antibodies that bind irreversibly |
| 12/06/2001 | WO2001013884A3 Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 12/06/2001 | WO2001007015A3 Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates |
| 12/06/2001 | WO2001005432A3 Conjugate for mediating cell, compartment or membrane-specific transport of active substances |
| 12/06/2001 | WO2000064427A3 Lamivudine containing pharmaceutical formulation |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | US20010049439 Therapeutic polymorphs of a GABA-A alpha-5 inverse agonist and pamoate formulations of the same |
| 12/06/2001 | US20010049422 Methods of applying antibiotic compounds to polyurethane biomaterials using textile dyeing technology |
| 12/06/2001 | US20010049386 Method of treating onychomycosis |
| 12/06/2001 | US20010049382 Or nicotinic acid esters |
| 12/06/2001 | US20010049361 Water-soluble dry compositions |
| 12/06/2001 | US20010049359 Treatment of hiv infection |
| 12/06/2001 | US20010049354 Protecting solid-state proteins from the effects of ionizing radiation |
| 12/06/2001 | US20010049353 Stimulating secretion of pancreatic juices |
| 12/06/2001 | US20010049349 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 12/06/2001 | US20010049107 Patient-specific library of antineoplastic antibodies or fragments; variable regions are linked, cloned into expression vectors, amplified; libraries transferred to other expression vectors without losing diversity |
| 12/06/2001 | US20010048947 Drug delivery |
| 12/06/2001 | US20010048946 Drug in water soluble polymer matrix |
| 12/06/2001 | US20010048941 Method for treating amyloidosis |
| 12/06/2001 | US20010048939 Cationic reagents of transfection |
| 12/06/2001 | US20010048931 Oral administering |
| 12/06/2001 | US20010048922 Stimulating immune response to taregted antigen; binding |
| 12/06/2001 | US20010048914 Radioactive therapeutic liposomes |
| 12/06/2001 | DE10026791A1 Mikronisiertes Bariumsulfat Micronized barium sulfate |
| 12/06/2001 | DE10026699A1 Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage Formulation of heparin, glycosaminoglycan or Heparinoidbasis and use of the formulation and the formulation base |
| 12/06/2001 | DE10026698A1 Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung Selfemulsifiable drug formulation and use of this formulation |
| 12/06/2001 | DE10025971A1 Transdermales therapeutisches System mit verminderter Tendenz zur Wirkstoffkristallisation Transdermal therapeutic system with reduced tendency for drug crystallization |
| 12/06/2001 | DE10025756A1 Lösungsvermittler Solubilizer |
| 12/06/2001 | DE10025671A1 Emulsifiers useful for producing phase inversion temperature or micro-emulsion, especially for cosmetics, comprises partial glycerides with low monoglyceride content plus alcohol polyglycol ether and fatty alcohol |
| 12/06/2001 | DE10024413A1 Pharmazeutische und/oder kosmetische Zubereitung Pharmaceutical and / or cosmetic preparation |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | CA2410882A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof |
| 12/06/2001 | CA2410675A1 Medicament-loaded transdermal reservoir and method for its formation |
| 12/06/2001 | CA2410650A1 Medicament for combating respiratory depression |
| 12/06/2001 | CA2410630A1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 12/06/2001 | CA2410589A1 Pharmaceutical compositions of 2'-deoxy-2'-(fluoromethylene)cytidine |
| 12/06/2001 | CA2410453A1 Neuroprotective peptides |
| 12/06/2001 | CA2410265A1 Lyophilizable and enhanced compacted nucleic acids |
| 12/06/2001 | CA2409188A1 Polyubiquitin based hydrogel and uses thereof |
| 12/06/2001 | CA2408793A1 Use of a celecoxib composition for fast pain relief |
| 12/06/2001 | CA2408103A1 Tumor activated prodrug compounds and methods of making and using the same |
| 12/06/2001 | CA2380769A1 Transdermal delivery of lasofoxifene |
| 12/06/2001 | CA2380367A1 Compositions for providing zinc through oral administration |
| 12/06/2001 | CA2375875A1 Low emulsifier multiple emulsions |
| 12/05/2001 | EP1160255A1 Monovalent antibody fragments |
| 12/05/2001 | EP1159975A2 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159974A1 Anti-angiogenic compositions and methods of use |
| 12/05/2001 | EP1159960A1 Pharmaceutical compositions based on diclofenac |
| 12/05/2001 | EP1159957A2 Device for the local administration of solid or semi-solid formulations, sustained release formulations for parenteral administration and process of preparation |
| 12/05/2001 | EP1159956A2 Anhydrous topical skin preparations |
| 12/05/2001 | EP1159882A2 Coating material and coated powder |
| 12/05/2001 | EP1159328A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 12/05/2001 | EP1159061A1 Chemical method for making pyrithione particle dispersions |
| 12/05/2001 | EP1159011A2 Surface modification of lamellar particles |
| 12/05/2001 | EP1159010A1 Treatment of diarrhea caused by enteropathogenic escherichia coli |
| 12/05/2001 | EP1159009A2 Use of niaouli essential oil as transdermal permeation enhancer |
| 12/05/2001 | EP1159008A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors |
| 12/05/2001 | EP1159007A1 Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds |
| 12/05/2001 | EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP1158979A2 Compositions of remifentanil |
| 12/05/2001 | EP1158970A1 Combinations of formoterol and a tiotropium salt |
| 12/05/2001 | EP1158964A1 Edible coating composition |
| 12/05/2001 | EP1158962A1 Method for producing solid dosage forms containing cyclodextrin |
| 12/05/2001 | EP1158958A1 Improved powdery pharmaceutical compositions for inhalation |
| 12/05/2001 | EP1158859A1 Iodine preparation compositon |
| 12/05/2001 | EP1084270A4 Inhibition of coagulation in blood and blood products |
| 12/05/2001 | EP1067904B1 Solid, quick dissolving cetirizine formulations |
| 12/05/2001 | EP1063983B1 Transdermal therapeutic system (tts) containing oxybutynin |
| 12/05/2001 | EP1051158B1 Pharmaceutical compositions in form of polymeric microparticles obtained by extrusion and spheronization |
| 12/05/2001 | EP1026947B1 Composition and method for treating penile erectile dysfunction |
| 12/05/2001 | EP1019039B1 Compressed nitroglycerin tablet and its method of manufacture |
| 12/05/2001 | EP0994693B1 Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin |
| 12/05/2001 | EP0955999B1 Novel liposome complexes for increased systemic delivery |
| 12/05/2001 | EP0912197B1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 12/05/2001 | EP0862414B1 Ophthalmic compositions containing cyclodextrins and quaternary ammonium compounds |
| 12/05/2001 | EP0859596B1 Gel formulations containing growth factors |
| 12/05/2001 | EP0814841B1 Hcg liquid formulations |
| 12/05/2001 | EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 12/05/2001 | EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 12/05/2001 | EP0792142B1 Fusogenic liposomes |
| 12/05/2001 | EP0786985B1 Method and composition for treatment of abnormal conditions of the epithelium of bodily orifices |
| 12/05/2001 | EP0754032B1 Liquid delivery compositions |
| 12/05/2001 | EP0721337B1 Oral formulations of an antifungal |
| 12/05/2001 | EP0706377B1 Sustained release excipient |
| 12/05/2001 | EP0697867B1 Compositions in the form of solid solutions |
| 12/05/2001 | EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER |
| 12/05/2001 | CN1325534A Apparatus and method for brachytherapy |
| 12/05/2001 | CN1325441A Modified exosomes and uses |
| 12/05/2001 | CN1325315A Implant with cavities containing therapeutic agents |
| 12/05/2001 | CN1325312A Muco-adhesive polymers, use thereof and method for producing the same |
| 12/05/2001 | CN1325310A Remedies for bone metabolic errors |
| 12/05/2001 | CN1325306A Pharmaceutical moxifloxacin preparation |
| 12/05/2001 | CN1325305A Method of administering camptothecin compounds for the treatment of cancer with reduced side effects |
| 12/05/2001 | CN1325302A Use of dialkylfumarates |